CircSMAD2 Inhibits the Epithelial–Mesenchymal Transition by Targeting miR-629 in Hepatocellular Carcinoma [Retraction]

Xianwei W Zhang, Ping Luo, Wei Jing, Hu Zhou, Chunzi Z Liang, Jiancheng C Tu

Open source

DOI
10.2147/ott.s665164
Published
2026-10
Container
OncoTargets and Therapy
Publisher
Informa UK Limited
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2147/ott.s665164,
  title = {CircSMAD2 Inhibits the Epithelial–Mesenchymal Transition by Targeting miR-629 in Hepatocellular Carcinoma [Retraction]},
  author = {Xianwei W Zhang and Ping Luo and Wei Jing and Hu Zhou and Chunzi Z Liang and Jiancheng C Tu},
  year = {2026},
  journal = {OncoTargets and Therapy},
  doi = {10.2147/ott.s665164},
  url = {https://doi.org/10.2147/ott.s665164}
}

RIS

TY  - JOUR
TI  - CircSMAD2 Inhibits the Epithelial–Mesenchymal Transition by Targeting miR-629 in Hepatocellular Carcinoma [Retraction]
AU  - Xianwei W Zhang
AU  - Ping Luo
AU  - Wei Jing
AU  - Hu Zhou
AU  - Chunzi Z Liang
AU  - Jiancheng C Tu
PY  - 2026
JO  - OncoTargets and Therapy
DO  - 10.2147/ott.s665164
UR  - https://doi.org/10.2147/ott.s665164
ER  - 

APA

Zhang, X. W., Luo, P., Jing, W., Zhou, H., Liang, C. Z., & Tu, J. C. (2026). CircSMAD2 Inhibits the Epithelial–Mesenchymal Transition by Targeting miR-629 in Hepatocellular Carcinoma [Retraction]. OncoTargets and Therapy. https://doi.org/10.2147/ott.s665164

Source records